Nitrogen-containing flavonoid analogues as CDK1/cyclin B inhibitors: Synthesis, SAR analysis, and biological activity

被引:85
作者
Zhang, Shixuan [1 ]
Ma, Jigang [1 ]
Bao, Yongming [2 ]
Yang, Puwen [1 ]
Zou, Liang [1 ]
Li, Kangjian [1 ]
Sun, Xiaodan [1 ]
机构
[1] Dalian Univ Technol, State Key Lab Fine Chem, Dalian 116012, Peoples R China
[2] Dalian Univ Technol, Sch Environm & Biol Sci & Technol, Dalian 116024, Peoples R China
关键词
flavonoid analogues; baicalein; CDK1/cyclin B inhibitor; SAR;
D O I
10.1016/j.bmc.2008.06.055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A series of nitrogen-containing flavonoid analogues were designed and synthesized by Mannich reaction, and screened for the inhibitory activities of cyclin-dependent kinases using a FRET-based biochemical assay method. The results showed that C-8 nitrogen-containing baicalein analogues 3a-3f exhibited potent CDK1/Cyclin B inhibitory activities. 5,6,7-Trihydroxy-8-(dimethylaminomethyl)-2-phenyl-4H-chromen-4-one 3a, 5,6,7-trihydroxy-8-(pyrrolid inylmethyl)-2-phenyl-4H-chromen-4-one 3b, and 5,6,7-trihydroxy-8-(piperidinylmethyl)-2-phenyl-4H-chromen-4-one 3c (IC50 1.05-1.28 mu M) were about sixfold more potent than baicalein 2 (IC50 6.53 mu M). 5,6,7-Trihydroxy-8-(morpholinomethyl)-2-phenyl-4H-chromen-4-one 3d, 5,6,7-trihydroxy-8-(thiomorpholinomethy)-2-phenyl-4H-chrom en-4-one 3e, and 5,6,7-trihydroxy-8-(4-methylpiperazinylmethyl)-2-phenyl-4H-chromen-4-one 3f (IC50 0.27-0.38 mu M) were about 20-fold more potent than baicalein, and were at the same level as flavopiridol (IC50 0.33 mu M). (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7127 / 7132
页数:6
相关论文
共 13 条
[1]
Design, synthesis, and antiproliferative and CDK2-cyclin A inhibitory activity of novel flavopiridol analogues [J].
Ahn, Yu Mi ;
Vogeti, Lakshminarayana ;
Liu, Chun-Jing ;
Santhapuram, Hari K. R. ;
White, Jonathan M. ;
Vasandani, Veena ;
Mitscher, Lester A. ;
Lushington, Gerald H. ;
Hanson, Paul R. ;
Powell, Douglas R. ;
Himes, Richard H. ;
Roby, Katherine F. ;
Ye, Qizhuang ;
Georg, Gunda I. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (02) :702-713
[2]
Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase [J].
deAzevedo, WF ;
MuellerDieckmann, HJ ;
SchulzeGahmen, U ;
Worland, PJ ;
Sausville, E ;
Kim, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) :2735-2740
[3]
Baicalein induces a dual growth arrest by modulating multiple cell cycle regulatory molecules [J].
Hsu, SL ;
Hsieh, YC ;
Hsieh, WC ;
Chou, CJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 425 (03) :165-171
[4]
KYOUNG SK, 2000, J MED CHEM, V43, P4126
[5]
Lee HZ, 2005, ANTICANCER RES, V25, P959
[6]
3-Hydroxychromones as cyclin-dependent kinase inhibitors: Synthesis and biological evaluation [J].
Lee, Jinho ;
Park, Taesik ;
Jeong, Shinwu ;
Kim, Kyoung-Hee ;
Hong, Changyong .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) :1284-1287
[7]
Nitrogen-containing flavonoids as CDK1/Cyclin B inhibitors: Design, synthesis, and biological evaluation [J].
Liu, Tao ;
Xu, Zhongmiao ;
He, Qiaojun ;
Chen, Yanhong ;
Yang, Bo ;
Hu, Yongzhou .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (01) :278-281
[8]
Structure-activity relationship studies of flavopiridol analogues [J].
Murthi, KK ;
Dubay, M ;
McClure, C ;
Brizuela, L ;
Boisclair, MD ;
Worland, PJ ;
Mansuri, MM ;
Pal, K .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (10) :1037-1041
[9]
Protein kinase inhibitors: Insights into drug design from structure [J].
Noble, MEM ;
Endicott, JA ;
Johnson, LN .
SCIENCE, 2004, 303 (5665) :1800-1805
[10]
Small molecule modulators of cyclin-dependent kinases for cancer therapy [J].
Senderowicz, AM .
ONCOGENE, 2000, 19 (56) :6600-6606